eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
4/2021
vol. 15
 
Share:
Share:
DISEASES AND PROBLEMS DISTINGUISHED BY WHO AND FAO
abstract:
Original paper

Adherence to treatment regimens in patients with cardiovascular disease

Lucia Dimunová
1
,
Jana Michalková
1
,
Mária Zamboriová
1
,
Jana Bučková
2
,
Iveta Rajničová Nagyová
2

1.
Department of Nursing, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Slovakia
2.
Department of Social and Behavioral Medicine, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Slovakia
Health Prob Civil. 2021; 15(4): 270-274
Online publish date: 2021/11/10
View full text Get citation
 
PlumX metrics:
Background
Adherence is an important parameter of any effective treatment. This study aimed to evaluate adherence/non-adherence in patients with cardiovascular diseases and to determine whether sociodemographic characteristics affected treatment adherence.

Material and methods
The study sample consisted of 878 patients with coronary heart disease. A non-standardized questionnaire was used to obtain the data. The data was statistically evaluated using SPSS.25.0.

Results
Adherence was demonstrated in 501 (57.4%) patients. A statistically significant relationship was confirmed between adherence to treatment and gender (p=0.000) and employment (p=0.001). Patients ≥58 years of age with basic education and who earn an average income have a higher adherence rate to treatment.

Conclusions
Knowledge of how a patient’s sociodemographic characteristics affect adherence can help healthcare professionals to effectively educate patients and improve their quality of life.

keywords:

treatment adherence, cardiovascular diseases, patients


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.